|
| Press Releases |
|
 |
|
| Monday, August 29, 2022 |
|
|
贝康医疗公布2022年中期业绩 做强技术创新 |
中国辅助生殖基因检测解决方案的创新平台苏州贝康医疗股份有限公司(“贝康医疗”或“公司”，及其子公司，统称“集团”；股份代号：2170) 公布截至 2022 年 6 月 30 日止六个月(“期内”)之未经审核综合业绩。
more info >> |
|
|
貝康醫療公佈2022年中期業績 做強技術創新 |
| 中國輔助生殖基因檢測解決方案的創新平台蘇州貝康醫療股份有限公司(「貝康醫療」或「公司」，及其子公司，統稱「集團」；股份代號：2170) 公佈截至 2022 年 6 月 30 日止六個月(「期內」)之未經審核綜合業績。 more info >> |
|
|
Strengthen technological innovation, Basecare Medical Announces 2022 Interim Results |
| Suzhou Basecare Medical Corporation Limited ("Basecare Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 2170), an innovative platform of genetic testing solutions for assisted reproduction in China, officially announced the unaudited consolidated interim results for the six months ended June 30, 2022 (the "Reporting Period"). more info >> |
|
| Thursday, July 14, 2022 |
|
|
贝康医疗与海尔生物强强联合，构建辅助生殖低温保存解决方案 |
| 苏州贝康医疗股份有限公司（以下简称“贝康医疗”）与青岛海尔生物医疗股份有限公司（以下简称“海尔生物”）正式签署战略合作协议。 more info >> |
|
|
貝康醫療與海爾生物強強聯合，構建輔助生殖低溫保存解決方案 |
| 蘇州貝康醫療股份有限公司（以下簡稱「貝康醫療」）與青島海爾生物醫療股份有限公司（以下簡稱「海爾生物」）正式簽署戰略合作協議。 more info >> |
|
|
Basecare Medical and Haier Biomedical Join Forces to Build Cryopreservation Solutions for Assisted Reproduction |
| Suzhou Basecare Medical Corporation Limited ("Basecare Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 2170) officially announced that the Company entered into a strategic collaboration framework agreement with Qingdao Haier Biomedical Co., Ltd. more info >> |
|
| Thursday, March 31, 2022 |
|
|
贝康医疗公布2021年全年业绩，收入毛利录得双增长 |
| 中国辅助生殖基因检测解决方案的创新平台苏州贝康医疗股份有限公司(“贝康医疗”或“公司”，及其子公司，统称“集团”；股份代号：2170) 公布截至2021年12月31日止年度(“年内”)之经审核综合业绩。 more info >> |
|
|
貝康醫療公佈2021年全年業績，收入毛利錄得雙增長 |
| 中國輔助生殖基因檢測解決方案的創新平台蘇州貝康醫療股份有限公司(「貝康醫療」或「公司」，及其子公司，統稱「集團」；股份代號：2170) 公佈截至2021年12月31日止年度(「年內」)之經審核綜合業績。 more info >> |
|
|
Basecare Announces 2021 Annual Results: Overall Increase in Revenue and Gross Profit |
| Suzhou Basecare Medical Corporation Limited ("Basecare" or the "Company", together with its subsidiaries, the "Group", stock code: 2170), an innovative platform of genetic testing solutions for assisted reproduction in China, announced its audited consolidated results for the year ended 31 December 2021 (the "Year"). more info >> |
|
| Wednesday, November 3, 2021 |
|
|
貝康醫療收購星博生物，產業外延到男科領域 |
| 2021年11月3日，蘇州貝康醫療股份有限公司（以下簡稱“貝康醫療”）收購浙江星博生物科技股份有限公司（以下簡稱“星博生物”）線上新聞發佈會成功舉行。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
益美国际拓展国际绿能布局，盈利前景广阔可期
Apr 16, 2024 18:11 HKT/SGT
|
|
|
益美國際拓展國際綠能佈局，盈利前景廣闊可期
Apr 16, 2024 18:08 HKT/SGT
|
|
|
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
Apr 16, 2024 18:04: JST
|
|
|
LEXUS、ミラノデザインウィーク2024に出展
Apr 16, 2024 18:00: JST
|
|
|
Lexus presents Time at the 2024 Milan Design Week
Apr 16, 2024 18:49 JST
|
|
|
中国抗体SM17治疗特应性皮炎（AD）之临床前结果刊登于国际科学期刊《Allergy》
Apr 16, 2024 17:48 HKT/SGT
|
|
|
中國抗體SM17治療特應性皮炎（AD）之臨床前結果刊登於國際科學期刊《Allergy》
Apr 16, 2024 17:44 HKT/SGT
|
|
|
SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy
Apr 16, 2024 17:35 HKT/SGT
|
|
|
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
Apr 16, 2024 17:04 HKT/SGT
|
|
|
三菱商事、米国ルイジアナ州におけるDACプロジェクトへの参画について
Apr 16, 2024 14:00: JST
|
|
|
NEC、SBTiからNet-Zero目標の認定を取得
Apr 16, 2024 14:00: JST
|
|
|
Mitsubishi Corporation Announces Participation in a DAC Project in Louisiana, USA
Apr 16, 2024 14:36 JST
|
|
|
Big CIO Show 2024 Paves the Way for Next-Gen Technological Leadership in AI
Apr 15, 2024 19:40 HKT/SGT
|
|
|
New circuit challenge for TOYOTA GAZOO Racing
Apr 15, 2024 17:21 JST
|
|
|
茶百道（2555.HK）正在招股：引领现制茶饮赛道 营收净利显著提升
Apr 15, 2024 15:02 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
